-
Covaxin granted restricted EUA
expresspharma
March 12, 2021
Bharat Biotech’s indigenously developed Covaxin is out of the “clinical trial mode” and it has now been granted the restricted emergency use authorisation.
-
J&J gets positive CHMP opinion for single-shot COVID-19 vaccine candidate
expresspharma
March 12, 2021
If granted conditional marketing authorisation by the EC, the J&J single-shot COVID-19 vaccine will be available in the EU.
-
Biotechs to test feasibility of a shelf-stable, powder mRNA COVID-19 vaccine
europeanpharmaceuticalreview
March 11, 2021
The collaborators hope to make mRNA COVID-19 vaccines accessible to all by creating a shelf-stable, reconstitutable powder formulation.
-
UK denies EU accusations of Covid-19 vaccine export bans
pharmaceutical-technology
March 11, 2021
The UK and the European Union (EU) are embroiled in a public diplomatic row about Covid-19 vaccine exports.
-
VBI Vaccines begins enrolment in Covid-19 vaccine candidate study
pharmaceutical-technology
March 11, 2021
VBI Vaccines has commenced enrolment in an adaptive Phase I/II clinical study of its enveloped virus-like particle (eVLP) Covid-19 vaccine candidate, VBI-2902.
-
US accuses Russia of Covid-19 vaccine disinformation campaign
pharmaceutical-technology
March 10, 2021
The US Government has accused the Russian intelligence services of carrying out a disinformation campaign aimed at undermining confidence in Western-produced Covid-19 vaccines, including Pfizer and BioNTech’s mRNA product.
-
Johnson & Johnson announces aingle-ahot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its Phase 3 ENSEMBLE trial
worldpharmanews
March 09, 2021
Johnson & Johnson announced top line efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key ...
-
Health Canada authorises J&J’s Covid-19 vaccine for emergency use
pharmaceutical-technology
March 09, 2021
Health Canada has authorised an Interim Order (IO) to the Janssen Pharmaceutical (JPI) Companies of Johnson & Johnson’s (J&J) single-shot vaccine preventing Covid-19 for people aged 18 above.
-
EU regulator advises caution on EUA for Sputnik COVID-19 vaccine
expresspharma
March 09, 2021
Sputnik V has already been approved or is being assessed for approval in three EU member states - Hungary, Slovakia and the Czech Republic.
-
SII asks government to intervene over import of COVID-19 vaccine raw material from US
expresspharma
March 09, 2021
The company said this would enable it to import essential products soon from the US for uninterrupted manufacturing and supply of COVID-19 vaccines in India and globally.